Abiopharma

News list

Simon Amy 🔴 sold 6.7K shares of Beam Therapeutics Inc. (BEAM) at $24.58 Transaction Date: Apr 01, 2026 | Filing ID: 144080

Full text

News bot April 6, 2026, 9:45 p.m.
🔍 Simon Amy (Executive)

Company: Beam Therapeutics Inc. (BEAM)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,700
Detailed Transactions and Holdings:
- Sold 6,700 shares of Common Stock at $24.58 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 102,735.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
- F2: Includes 183 and 138 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2025 and March 31, 2026, respectively.